Noonan Syndrome with Multiple Lentigines in an Adolescent Female: A Case of PTPN11-associated Lentiginosis with a Confirmed Pathogenic Variant

Read full text Summarise with VIRAT
Authors: Vijayasankar Palaniappan, Ragavi Balasubramanian, Kaliaperumal Karthikeyan
Cited by: 0
References: 8

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Madam, A 16-year-old girl presented with progressively increasing lentigines since the age of six, predominantly involving the face, trunk, and upper limbs. Two well-defined café-au-lait macules had been noted since early childhood. There was no family history of similar pigmentary lesions. On examination, multiple 1–5 mm dark brown lentigines were observed over the face, neck, upper chest, back, and upper extremities [Figure 1a]. Two café-au-lait macules, measuring 2 cm and 4 cm, were present on the back [Figure 1b]. Growth parameters were appropriate for age and sex. No facial dysmorphism was noted.Figure 1: (a) Clinical images show multiple lentigines distributed over the face and neck, (b) Generalized lentigines over the posterior trunk, with a café-au-lait macule visible on the lower backSystemic evaluation – including electrocardiogram (ECG), echocardiogram, audiometry, ophthalmologic examination, and skeletal survey – revealed no abnormalities. Genetic testing identified a heterozygous c. 836A > G (p.Tyr279Cys) missense variant in the PTPN11 gene [Figure 2]. This variant is classified as pathogenic (Class V) according to ACMG criteria and is supported by data from ClinVar and previous literature. It lies within a known mutational hotspot and has been previously associated with Noonan syndrome with multiple lentigines (NSML), formerly termed LEOPARD syndrome.[1]Figure 2: Genetic analysis by clinical exome and whole mitochondrial genome sequencing identified a pathogenic variant in the PTPN11 gene: C.836A>G (p.Tyr279Cys), located in exon 7 at chromosomal position 12:112910827 A > G (bottom right)The combination of characteristic pigmentary findings and a confirmed pathogenic variant established the diagnosis of NSML. The patient is under regular 3-monthly follow-up for surveillance of potential systemic manifestations, particularly cardiac and auditory complications, which may appear later in life. NSML is a rare autosomal dominant RASopathy characterized by widespread lentigines, café-au-lait macules, and variable systemic involvement. Mutations in PTPN11, especially the p.Tyr279Cys variant, are well-established in NSML and are known to impair Src homology-2-containing protein tyrosine phosphatase 2 (SHP-2) activity, contributing to disease pathogenesis.[1,2] This patient presented with early-onset, progressive lentiginosis and café-au-lait macules but lacked facial dysmorphism, cardiac abnormalities, or auditory deficits – features commonly seen in NSML. Similar cases with isolated cutaneous findings and no systemic involvement have been reported in the literature.[3,4] The absence of systemic abnormalities at presentation highlights the phenotypic variability of NSML and underscores the potential for delayed diagnosis when extracutaneous features are absent. Table 1 summarizes the cutaneous and systemic findings of Noonan syndrome with lentiginosis.[5,6] Other conditions presenting with lentiginosis and café-au-lait macules include Peutz–Jeghers syndrome and Carney complex.[7-9] An algorithm outlining the approach to conditions with lentiginosis and café-au-lait macules is provided in Figure 3.Table 1: Cutaneous and systemic findings of Noonan syndrome with lentiginosisFigure 3: Algorithm for the evaluation of conditions presenting with lentiginosis and café-au-lait maculesLong-term care of patients with NSML involves regular monitoring of growth on syndrome-specific charts, ongoing cardiac evaluation with echocardiogram and ECG, and screening for hearing and vision problems. Neurological assessment, including magnetic resonance imaging if seizures or developmental delay are present, and developmental testing to guide early intervention, are recommended. Male patients require evaluation for cryptorchidism, while renal ultrasound is advised if urinary anomalies are suspected. Musculoskeletal monitoring for scoliosis or chest wall deformity may need orthopedic input. Genetic counseling and access to family support services complete the multidisciplinary follow-up.[1] This case underscores the importance of considering NSML in children with generalized lentiginosis, even in the absence of systemic features. Molecular diagnosis not only facilitates accurate identification but also informs prognosis, genetic counseling, and long-term monitoring. Declaration of patient consent The authors certify that they have obtained all appropriate consent forms, duly signed by the parent(s)/guardian(s) of the patient. In the form, the parent(s)/guardian(s) has/have given his/her/their consent for the images and other clinical information of their child to be reported in the journal. The parents understand that the names and initials of their child/children will not be published, and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.

Fields of Study & Subjects

Protein Tyrosine Phosphatases Genetic and rare skin diseases. Genomics and Rare Diseases

Publication details

Journal / source
Indian Journal of Paediatric Dermatology
Volume
27
Issue
1
Pages
76–78
Publication date
1 January 2026
Language
EN